publication date: Dec. 18, 2010
In this issue:
Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.
FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.
Patients “Raise A Voice” For Provenge Approval.
Ad Hoc Internet Group Send Rebuttal To Scher’s Letter.
Download (PDF 712KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.